Half Of Europe's Workforce Remain Unprotected From Secondhand Smoke At Work |
![]() |
Half Of Europe's Workforce Remain Unprotected From Secondhand Smoke At Work![]() Less than a third of European Union's Member States have introduced fully comprehensive smokefree legislation, three years after world's first public health treaty on tobacco control - World Health Organisation ( WHO ) Framework Convention on Tobacco Control ( FCTC ) - introduced the need for protecting employees from dangerous effects of secondhand smoke. Today's 'Spotlight on FCTC*' reveals how only nine of the 25 EU Member States that have signed and ratified the WHO treaty have so far introduced comprehensive smokefree legislation - leaving over half of Europe's workforce exposed to secondhand smoke. When tobacco smoke contaminates the air, it's breathed by everyone - smokers and non-smokers alike. There are more than 4, 000 chemicals in tobacco smoke including 69 known carcinogens. Comprehensive smokefree legislation has been introduced in Estonia, Finland, France, Ireland, Italy, Malta, Slovenia, Sweden and UK. Jean-Luc Eisel, Executive Director at European Respiratory Society said: " The scientific evidence is clear: secondhand smoke kills. Only comprehensive smoke free legislation fully protects workers from detrimental effects of second hand smoke. We congratulate those countries that have taken steps necessary to become smokefree, but all workers in EU should have same level of protection " Jean King, Director of Tobacco Control at Cancer Research UK added: " Countries that have already introduced comprehensive smokefree legislation are finding that the legislation is workable and has almost immediate health benefits. We hope these examples will encourage countries that haven't yet taken necessary action to introduce smokefree workplaces to do so as soon as possible. " The Framework Convention on Tobacco Control ( FCTC ) aims to protect people from health, economic and social impacts of tobacco. It recognises that secondhand exposure to tobacco smoke has been scientifically proven to cause death, disease and disability. Countries that have signed and ratified FCTC are required to reflect its principles in their national legislation and polices including provisions concerning second hand smoke. 'Spotlight on FCTC' , prepared by Smokefree Partnership, highlights how European Commission, European Parliament and EU Member States have met, or in some cases failed to meet, their obligations to tackle second hand smoke, according to Article 8 of convention. The booklet also draws attention to fact European Parliament failed to maintain its own comprehensive smoking ban, which was introduced in January 2007, and lasted 43 days before being revoked by governing body of MEPs. A ruling by European Ombudsman found that Parliament was failing to protect the health of its staff. A 2007 Parliamentary report led by MEP Karl Heinz Florenz in response to a Commission Green Paper on a smokefree Europe, states that 'only a full smoking ban in all enclosed workplaces, including catering and drinking establishments, and all public buildings and transport, can protect health of employees and non smokers'. The report also called on the Parliament's Bureau, in light of its duty to set an example, to implement a full smoking ban in all parts of Parliament - but no action has yet been taken. MEP Gerard Onesta said: " The alarming decision by the European Parliament to scrap its own smokefree rules highlights a dangerous disregard some MEP's have for health of those workers affected. Their original commitment to a smokefree European Parliament showed they understood dangers of secondhand smoke. They urgently need to lead by example and reverse this disastrous setback for future of a healthy Europe. " MEP Karl Heinz Florenz added: I will continue to fight for strong smoke free policies at national and European level as well as in European Parliament itself. MEPs and European Parliament as an institution should live up to their public health responsibilities and take lead on this issue. The smoking ban in European Parliament needs to be put into effect now! This article has been written on behalf of European Respiratory Society and Cancer Research UK. The Smoke Free Partnership ( SFP ) is strategic, independent and flexible and aims to promote tobacco control advocacy and policy research at EU and national levels in collaboration with other EU health organisations and EU tobacco control networks. The 'Spotlight on FCTC' is a series of briefing papers on the FCTC and EU's associated obligations prepared by Smokefree Partnership. Smokefree Partnership 49-51 rue de Trves, 1040 Brussels http: //www. smokefreepartnership. eu The FCTC The FCTC is world's first international public health treaty. It recognises harm that tobacco products and the companies that produce them can cause. The Treaty sets out legally binding objectives and principles that countries or regional economic integration organisations such as European Community ( known as Parties ) who ratified and thus agreed to implement Treaty must follow. All EU Member States, with exception of Italy and the Czech Republic, have signed and ratified FCTC so principles of Treaty must be reflected in their national legislation and polices. The European Community ( EC ) , represented by European Commission, is also a Party to FCTC. The Framework Convention Alliance for Tobacco Control ( FCA ) Where to buy quality low priced medicine |
What you have to know before use Valtrex.uses of Valtrex Valtrex is used to treat cold sores ( herpes labialis ) and shingles ( herpes zoster ) . It is also used to treat genital herpes in patients with normal immune systems. Valtrex can also be used to control genital herpes outbreaks in all patients, including those with HIV. This is also known as suppressive therapy. Valtrex helps control symptoms, but doesn't cure the disease. how to use of Valtrex Read the Patient Information Leaflet available from your pharmacist. Consult your doctor or pharmacist if you have any questions. other used of Valtrex This section contains uses of Valtrex that aren't listed in approved professional labeling for the drug but that may be prescribed by your health care professional. Use Valtrex for a condition that's listed in this section only if it has been so prescribed by your health care professional. side effects of Valtrex Nausea, vomiting, fatigue, headache, dizziness, stomach pain, painful periods may occur while use Valtrex. If any of these effects persist or worsen, notify your doctor or pharmacist promptly. precautions of Valtrex Before taking Valtrex, tell your doctor or pharmacist if we are allergic to it or to acyclovir; or if we have any other allergies. interactions of Valtrex Your healthcare professionals ( e. g. , doctor or pharmacist ) may already be aware of any possible drug interactions and may be monitoring we for it. Don't start, stop or change dosage of any medicine before checking with them first. Valtrex with EU delivery |
FDA 101: Human Gene Therapy. Human gene therapy has the potential to revolutionize how many medical conditions are treated. FDA is working to ensure that research in this developing field is conducted responsibly and safely. OTC Cough and Cold Products: Not For Infants and Children Under 2 Years of Age, Questions and Answers for Consumers. FDA strongly recommends that over-the-counter (OTC) cough and cold products should not be used in infants and children under 2 years of age. Charges Filed in Contaminated Pet Food Scheme. An FDA investigation into a scheme to import contaminated ingredients used in pet food led to indictments against firms and their owners. Facts About Crohn's Disease. On January 14, 2008, FDA approved Tysabri (natalizumab) for certain patients with moderate-to-severe Crohn's disease, a chronic inflammatory condition of the digestive tract. Here are facts about the symptoms and treatments for this condition. FDA 101: Medication Errors. There have been adverse events and deaths in children and adults due to the misuse of Tussionex, a long-acting prescription cough medicine. Learn more about this and other medication errors that have been reported to FDA. |
AHN - Researchers Find Breast-Feeding Mother's Diets Influences Babies Tastes. The types of foods mothers eat an hour before breast-feeding their baby greatly influence children's preferences later on, according to new research. Fri, 25 Jul 2008 05:15:32 GMT. AHN - Carbofuran Residue On Food Banned By The EPA. The U.S. Environmental Protection Agency said Thursday it will ban the pesticide carbofuran on domestic or imported food, in effect prohibiting the chemical in the U.S. Fri, 25 Jul 2008 10:58:42 GMT. AHN - Ohio Legislation Would Protect Nursing Home Residents From Sex Offenders. The father of an 18-year old schizophrenic mentally retarded girl raped by a nursing home resident is battling for legislation that would mandate posting the names of residents with sex offense records. Fri, 25 Jul 2008 11:19:19 GMT. AHN - EPA Wants To Ban Carbofuran Pesticide Residue On Food Crops Now; Plans To Ban Use Later. United States Environmental Protection Agency officials told AHN Media Corp. on Friday that the proposed ban on detectable residue of the pesticide carbofuran on food crops it announced Thursday is only the beginning because the agency plans to ban use of carbofuran in the future. Fri, 25 Jul 2008 14:36:34 GMT. AHN - California Begins Trans Fat Ban At Restaurants. Following the lead of cities like New York and Philadelphia, California governor Arnold Schwarzenegger signed legislation on Friday banning the use of trans fats in restaurants throughout California. Fri, 25 Jul 2008 16:52:55 GMT. AHN - Anthrax Hits Cattle At Canadian Province Farms. The Canadian Food Inspection Agency has confirmed two cases of cattle deaths from anthrax this week in separate farms in Saskatchewan province. The disease poses no risk to humans. Fri, 25 Jul 2008 19:02:55 GMT. |
Half Of Europe's Workforce Remain Unprotected From Secondhand Smoke At Work What you have to know before use Valtrex. Valtrex with EU delivery FDA 101: Human Gene Therapy. Human gene therapy has the potential to revolutionize how many medical conditions are treated. FDA is working to ensure that research in this developing field is conducted responsibly and safely. Where to buy quality low priced medicine |
-->